Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML. [electronic resource]
Producer: 20111018Description: 1472-80 p. digitalISSN:- 1528-0020
- Acute Disease
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Azacitidine -- administration & dosage
- Cytarabine -- administration & dosage
- DNA Methylation -- drug effects
- Daunorubicin -- administration & dosage
- Decitabine
- Diarrhea -- chemically induced
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fever -- chemically induced
- Humans
- Infections -- chemically induced
- Kaplan-Meier Estimate
- Leukemia, Myeloid -- drug therapy
- Male
- Middle Aged
- Nausea -- chemically induced
- Neutropenia -- chemically induced
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.